Ki-Hyun Kim

Ki-Hyun Kim


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
YPYoung-Lan Park
Young-Lan Park
SPSun-Young Park
Sun-Young Park
HOHyung-Hoon Oh
Hyung-Hoon Oh
MCMin-Woo Chung
Min-Woo Chung
JHJi-Yun Hong
Ji-Yun Hong
YJYoung-eun Joo
Young-eun Joo
A disintegrin and metalloprotease 12 (ADAM12) has been implicated in cell growth, tumor formation, and metastasis. Therefore, we evaluated the role of ADAM12 in colorectal cancer (CRC) progression and prognosis, and elucidated whether targeted downregulation of ADAM12 could lead to therapeutic sensitization. The effect of ADAM12 on tumor cell behavior was assessed in CRC cell lines, CRC tissues, and a mouse xenograft model. ADAM12 overexpression enhanced proliferation, inhibited apoptosis, and acted as positive regulator of cell cycle progression in CRC cells. Phosphorylation of PTEN was decreased and that of Akt was increased by ADAM12 overexpression. These results were reversed upon ADAM12 knockdown. ADAM12 overexpression was significantly associated with the cancer stage, depth of invasion, lymph node metastasis, distant metastasis, and poor survival in CRC patients. In a mouse xenograft model, tumor area, volume, and weight were significantly greater for the ADAM12-pcDNA6-myc-transfected group than for the empty-pcDNA6-myc-transfected group, and significantly lower for the ADAM12-pGFP-C-shLenti-transfected group than for the scrambled pGFP-C-shLenti-transfected group. In conclusion, ADAM12 overexpression is essential for the growth and progression of CRC. Furthermore, ADAM12 knockdown reveals potent anti-tumor activity in a mouse xenograft model. Thus, ADAM12 may serve as a promising biomarker and/or therapeutic target in CRC.

11 March 2024 in Gut and Liver
Verified
Journal Article
Open access
PDF file
HCHyung Ku Chon
Hyung Ku Chon
KKKi-Hyun Kim
Ki-Hyun Kim
TSTae Jun Song
Tae Jun Song
DADong-Won Ahn
Dong-Won Ahn
ELEaum Seok Lee
Eaum Seok Lee
MCMiyoung Choi
Miyoung Choi
Hyung Ku Chon, Ki-Hyun Kim, Tae Jun Song, Dong-Won Ahn, Eaum Seok Lee, Yun Nah Lee, Yoon Suk Lee, Tae Joo Jeon, Chang Hwan Park, Kwang Bum Cho, Dong Wook Lee, Jin-Seok Park, Seung Bae Yoon, Kwang Hyun Chung, Jin Lee, Miyoung Choi. Gut and Liver 2024;18:564-77. https://doi.org/10.5009/gnl230427

10 December 2025 in The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Verified
Journal Article
Open access
PDF file
JKJe Seong Kim
Je Seong Kim
YSYoungEun Seo
YoungEun Seo
CLChae June Lim
Chae June Lim
CIChan Muk Im
Chan Muk Im
HOHyung Hoon Oh
Hyung Hoon Oh
WLWan Sik Lee
Wan Sik Lee
Objectives: Early diagnosis of upper gastrointestinal (UGI) amyloidosis and the establishment of appropriate treatment and follow-up strategies remains challenging. This study aimed to elucidate the endoscopic characteristics and clinical courses of patients with isolated UGI amyloidosis. Methods: We retrospectively reviewed 11 patients diagnosed with isolated UGI amyloidosis at Chonnam National University Hospital and Chonnam National University Hwasun Hospital. None of the patients exhibited systemic involvement or multiple myeloma. Clinical data, including endoscopic features, presenting symptoms, and outcomes such as disease progression and mortality, were analyzed. Results: The cohort included seven males (63.6%) and four females (36.4%), with a median age of 72 (37–82) years. Isolated gastric amyloidosis was identified in four patients, and five patients had disease confined to the duodenum. Two patients (18.2%) presented with gastric or duodenal involvement. Endoscopic findings were heterogeneous, with diffuse yellowish linear lesions being the most frequently observed in four patients (36.4%). Histopathological analysis revealed AA amyloidosis in three patients, whereas five patients exhibited only amorphous deposits without amyloid A, amyloid P, or light chains. Six patients (54.5%) were asymptomatic at diagnosis, whereas gastrointestinal bleeding was observed in two patients (18.2%). Only one patient (9.1%) experienced disease progression that necessitated systemic chemotherapy. The mean follow-up duration was 20 months, and the 3-year mortality rate was 9.1%. Conclusions: Isolated UGI amyloidosis is a heterogeneous condition that can be easily misdiagnosed. Familiarity with the characteristic endoscopic features and natural disease course is essential for appropriate management.

31 October 2024 in The Korean Journal of Pancreas and Biliary Tract
Verified
Journal Article
Open access
PDF file
KKKi-Hyun Kim
Ki-Hyun Kim
HCHyung Ku Chon
Hyung Ku Chon
TSTae Jun Song
Tae Jun Song
DADong Won Ahn
Dong Won Ahn
ELEaum Seok Lee
Eaum Seok Lee
JJJin Jin
Jin Jin
Endoscopic retrograde cholangiopancreatography (ERCP) is a procedure that requires abundant clinical experience and endoscopic skills, and can lead to various complications, some of which may progress to life-threatening conditions. With expanding indications and technological advancements, ERCP is widely utilized, enhancing procedural accessibility. However, without proper quality management, the procedure can pose significant risks. Quality management in ERCP is essential to ensure safe and successful procedures and meet societal demands for improved healthcare competitiveness. To address these concerns, the Korean Pancreatobiliary Association has developed a Korean-specific ERCP quality indicator reflecting domestic medical environments and realities. Initially, based on a review of foreign ERCP quality indicators and related literatures, key questions were formulated for five preprocedural items, three intra-procedural items, and four post-procedural items. Descriptions and recommendations for each item were selected through peer evaluation. The developed Korean-specific ERCP quality indicator was reviewed by external experts based on the latest evidence and consensus in this fields. This Korean-specific indicator is expected to significantly contribute to improving ERCP quality in Korea, as it is tailored to local needs.

20 April 2026 in Journal of Digestive Cancer Research
Verified
Journal Article
Open access
PDF file
JKJe Seong Kim
Je Seong Kim
WLWon Jae Lee
Won Jae Lee
CLChae June Lim
Chae June Lim
YSYoungEun Seo
YoungEun Seo
CIChan Muk Im
Chan Muk Im
YJYoung-eun Joo
Young-eun Joo
Je Seong Kim, Won Jae Lee, Chae June Lim, Young Eun Seo, Chan Muk Im, Hyung Hoon Oh, Ki-Hyun Kim, Young Eun Joo. Journal of Digestive Cancer Research 2026;14:115-9. https://doi.org/10.52927/jdcr.2026.14.1.115

31 July 2024 in The Korean Journal of Pancreas and Biliary Tract
Verified
Journal Article
Open access
PDF file
KKKi-Hyun Kim
Ki-Hyun Kim
Autoimmune pancreatitis is characterized by infiltration of the pancreas parenchyma by immunoglobulin G4 (IgG4)-positive plasma cells, chronic inflammation, and fibrosis. It can affect the entire body depending on the subtype. Distinguishing mass-forming type autoimmune pancreatitis from pancreatic cancer can often be challenging. A 60-year-old male presented to our outpatient clinic with abdominal discomfort. Computed tomography revealed a 4.8 cm mass in the pancreatic head obstructing the common bile duct. Endoscopic ultrasound-guided fine needle biopsy and endoscopic retrograde cholangiopancreatography with biliary drainage were performed. Pathological examination revealed no malignant cells, but more than 20 IgG4-positive cells were observed. Following two weeks of steroid treatment, the patient’s symptoms improved, and follow-up imaging showed a reduction in the size of the pancreatic head mass. Herein, we report a case of mass-forming autoimmune pancreatitis initially misdiagnosed as pancreatic cancer.